Evaluation of ureterorenoscopic stone therapy - results with regard to complications, quality of life and stone-free rate

Evaluation of ureterorenoscopic stone therapy - results with regard to complications, quality of life and stone-free rate - BUSTER

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00007668

Enrollment

263

Registered

2015-01-09

Start date

2015-01-12

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N20

Interventions

Group 1: In patients with uretererenoscopic stone therapy complications, quality of life and stone-free rate are checked perioperatively and in the 30-day course

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Consent-capable patient who undergoes a ureterorenoscopic stone therapy

Exclusion criteria

Exclusion criteria: Incapacitated patients

Design outcomes

Primary

Measure	Time frame
Quality of life and complications after ureterorenoscopic stone therapy (URS). Assessing Quality of Life with the Health Survey SF-8-Questionnaire and IPSS 30 days postoperatively. Detection of complications after Clavien-Dindo (grade 0-5) perioperatively and 30 days postoperatively.	—

Secondary

Measure	Time frame
Reintervention after URS	—

Countries

Germany

Contacts

Public ContactSteffen Lebentrau

Ruppiner Kliniken GmbH / Medizinische Hochschule Theodor Fontane

uro@ruppiner-kliniken.de004933913947310

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026